Novel Inhibitors of the Histone-Methyltransferase DOT1L Show Potent Antileukemic Activity in Patient-derived Xenografts.
Journal article published in 2020 by
Florian Perner,
Jayant Y. Gadrey,
Yijun Xiong,
Charles Hatton 
,
Benjamin K. Eschle,
Andreas Weiss,
Frédéric Stauffer,
Christoph Gaul,
Ralph Tiedt,
Jennifer A. Perry,
Scott A. Armstrong,
Andrei V. Krivtsov
,
Benjamin K. Eschle,
Andreas Weiss,
Frédéric Stauffer,
Christoph Gaul,
Ralph Tiedt,
Jennifer A. Perry,
Scott A. Armstrong,
Andrei V. Krivtsov
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 